INDIA Cases - 174,020, Deaths - 4,981
Global Cases - 6,048,213, Deaths - 367,225
Recently Scientists have found 6 kinds of drug candidates from more than 10,000 types of compounds that can effectively help in the treatment of the Coronavirus (COVID-19) all over the world. Rapidly spreading of the Coronavirus in all over the country, the Professor Luke Guddat from the University of Queensland in Australia said in a statement that there are no targeted therapeutics or effective treatment options for COVID-19 outbreak. Most of the scientist are researching various types of vaccine, medicine, drugs, etc to prevent COVID-19's infected people around the world.
Guddat said that in order to rapidly discover lead compounds for clinical use, we currently organized a program of high-throughout drug screening, they find them as well as in the laboratory and by using of computer software to estimate how different drugs bind to the virus.
Researchers also said that the project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in moderating viral reproduction.
This makes it a different kind of an attractive drug target for this virus, and people do not have this enzyme in their bodies, and compounds that target it are likely to have low toxicity, said a Researcher in his statement.
Guddat also added in this statement, that these drugs will be directly added to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the coronavirus (COVID-19).
After researching a lot, the researchers found the six kinds of the drug mainly for treating the Coronavirus infected people in inhibiting the enzyme. Researching on these six drugs are continued, and the result of these given very soon said an officer.
Professor Luke Guddar of university Queensland tested and approved the six drug candidates in clinical trials and other compounds. Also said that if the amount is low then we have a promising compound for further studies.